Drug Profile
Solpecainol
Alternative Names: EGIS 2936; EGYT 2936Latest Information Update: 25 Mar 1995
Price :
$50
*
At a glance
- Originator Egis Pharmaceuticals
- Class Class Ia antiarrhythmics; Class Ib antiarrhythmics
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias
Most Recent Events
- 25 Mar 1995 Discontinued-II for Angina pectoris in Hungary (Unknown route)
- 25 Mar 1995 Discontinued-II for Arrhythmias in Hungary (Unknown route)